Ventricular assist devices (VADs) are a viable option for treatment of end stage heart failure. Complications include infection, bleeding, thrombosis and even development of Ventricular Tachycardias (VT) A 65 year old female presented with severe biventricular cardiac failure.

2019年12月19日 · The prevalence of VA, defined as sustained ventricular tachycardia or fibrillation requiring defibrillation or ICD therapy, was compared between BIVAD patients and a propensity-matched population of patients with LVAD from our center.

While left ventricular assist device (LVAD) therapy alone is effective in many instances, up to 50% of LVAD recipients demonstrate clinically significant postoperative right ventricular failure and potentially need a biventricular assist device (BiVAD). In these cases, the BiVAD can effectively support both sides of the failing heart.

2018年5月23日 · We report safe and successful VT ablation utilizing transseptal access and bivalirudin in a patient with a BIVAD configured with a right atrial inflow cannula.

Ventricular arrhythmias (VAs) are common in patients post-left VAD (LVAD) implantation and are associated with considerable morbidity from recurrent implantable cardioverter-defibrillator (ICD) shocks and progressive failure of the unsupported right …

VAD-related VT is predominantly related to pre-existing intrinsic myocardial scar rather than inflow cannula site insertion. Catheter ablation is a reasonable treatment strategy, albeit with expectedly high rate of recurrence, transplantation, and mortality related to severe underlying disease.

2015年7月1日 · Ventricular tachycardia may cause hemodynamic sequelae even in patients with biventricular assist devices. Ventricular assist devices (VADs) are playing a large role in the management of end-stage heart failure.

2023年7月3日 · Experience with durable biventricular assist devices (BiVADs) as a bridge to heart transplantation (HTx) is limited, particularly in women. A 41-year-old woman with biventricular failure complicated by cardiogenic shock underwent durable concurrent BiVAD implantation and was supported for 1212 days as a bridge to HTx.

2019年12月14日 · The prevalence of VA, defined as sustained ventricular tachycardia or fibrillation requiring defibrillation or ICD therapy, was compared between BIVAD patients and a propensity-matched population of patients with LVAD from our center. The occurrence of adverse clinical events was compared between BIVAD patients with and without VA.

2005年8月30日 · Support with BiVAD offers an acceptable rate of survival to cardiac transplantation. Furthermore, the use of a BiVAD itself does not confer an increased morbidity or mortality, and overall outcomes with this device are comparable to that of implantable LVADs if used strategically in severe congestive heart failure.